National Association of Testing Authorities, Australia
Scope of Accreditation
Melbourne Pathology Pty Ltd
Sonic Healthcare Pty Ltd
Site
Central Laboratory
Accreditation No.
2133
Site No.
2126
Date of Accreditation
08 Dec 1986
Contact
Mrs Louise Douglas P: +61 (03) 92877716
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Chemical Pathology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma | Ethanol |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin; Everolimus; Sirolimus; Tacrolimus |
| Serum | Carbamazepine; Digoxin; Lithium; Phenytoin (dilantin); Valproate (valproic acid, epilim) | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Cyst fluid | Carcinoembryonic antigen (CEA) |
| Fine needle aspirates (FNA); Needle washings | Thyroglobulin | |
| Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Human chorionic gonadotropin (hCG); Prostate specific antigen (PSA) fractions and derived index; Thyroglobulin; α-Fetoprotein (AFP); β2-Microglobulin (B2M) | |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Fine needle aspirates (FNA); Needle washings | Parathyroid hormone (PTH) |
| Plasma | Adrenocorticotropic hormone (ACTH); Parathyroid hormone (PTH) | |
| Plasma; Serum | Procalcitonin | |
| Saliva | Cortisol | |
| Serum | Anti-Mullerian hormone (AMH) | |
| C-peptide; Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Macroprolactin; Oestradiol; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Adrenocorticotropic hormone (ACTH); Parathyroid hormone (PTH) | ||
| Chemical pathology - Further investigation of cardiac function | Serum | Troponin I |
| Troponin T | ||
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Bile acids; Caeruloplasmin; α1-Antitrypsin |
| Urine | Uric acid | |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Serum | Haptoglobins | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Ascitic fluid; Cyst fluid; Drainage fluid; Pleural fluid | Albumin; Amylase; Bilirubin - Total; Calcium - Total; Chloride; Cholesterol - Total; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea |
| Ascitic fluid; Drainage fluid; Faeces; Pleural fluid | pH | |
| Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total | |
| Cyst fluid | Amylase | |
| Faeces | Chloride; Potassium; Sodium | |
| Pericardial fluid | Glucose; Lactate dehydrogenase (LDH); Protein - Total | |
| Peritoneal dialysis fluid | Creatinine; Glucose; Urea | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Angiotensin converting enzyme (ACE); Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - HDL; Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; Uric acid; γ-Glutamyltransferase | |
| Serum; Urine | Osmolality | |
| Synovial fluid | Glucose; Lactate dehydrogenase (LDH); Protein - Total; Uric acid | |
| Urine | Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urea | |
| Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urea | ||
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Investigation of Helicobacter pylori colonisation or eradication | Breath | C14 |
| Chemical pathology - Iron studies | Serum | Ferritin; Iron; Transferrin |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine |
| Chemical pathology - Quantitation of vitamins | Serum | Cobalamin (vitamin B12); Holotranscobalamin (active vitamin B12) |
| Vitamin D | ||
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Plasma; Serum | Free light chains |
| Serum | Protein classes | |
| Urine | Protein classes | |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Serum | Human chorionic gonadotropin (hCG) |
Cytogenetics
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques | Blood; Products of conception (POC); Tissues | Chromosomal rearrangement; Constitutional genetic abnormalities; Cytogenetic analysis and reporting |
| Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalities | Blood | Constitutional genetic abnormalities; Cytogenetic analysis and reporting |
| Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Blood; Chorionic villus tissue; Other tissues - Non-malignant; Products of conception (POC) | Absence of heterozygosity; Aneuploidy detection for chromosomes; Chromosomal rearrangement; Cytogenetic analysis and reporting; Pathogenic copy number changes; Uniparental or biparental chromosome inheritance; Variants of uncertain significance (VUS) |
Cytopathology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens from cervix | Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Liquid based cytology specimens; Vaginal smears; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Aspirates; Bronchial lavage; Cerebrospinal fluid (CSF); Ocular specimens; Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program | Liquid based cytology specimens from cervix; Liquid based cytology specimens from vaginal vault | Human papilloma virus (HPV) |
| Human papilloma virus (HPV); Cytological examination; Review and reporting of cervical cytological material | ||
| Self-collected vaginal swabs | Human papilloma virus (HPV) | |
| Human papilloma virus (HPV) |
Haematology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A (HbA) - Quantitation; Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Bone marrow | Iron |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cell antigens |
| Haematology - Full blood examination | Blood | Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Morphology; Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes |
| Morphology | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet function (PFA) |
| Plasma | Activated partial thromboplastin time (APTT); Activated protein C (APC) resistance; Anti-Xa activity; Anti-thrombin III; D-dimer; Factor IX; Factor VIII; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Protein C and protein S; Prothrombin time (PT) | |
| Haematology - Investigation of haemolysis | Blood | Hereditary spherocytosis; Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | Assessment of lymphoid cell populations |
| Blood; Bone marrow; Disaggregated tissues specimen; Fresh tissue; Serous fluid | Leukaemia screen; Lymphoma screen | |
| Immunopathology - Single HLA antigen typing | Blood | HLA-B27 |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Blood | Plasmodium falciparum; Plasmodium knowlesi; Plasmodium malariae; Plasmodium ovale; Plasmodium vivax |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Haemochromatosis; Prothrombin variant |
Histopathology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities; Structured reporting |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Detection of antigenic targets - Various |
Immunohaematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Detection and quantitation of foetal red cells; Feto-maternal haemorrhage (FMH) estimation; Presence of foetal red blood cells |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution; Red blood cell phenotyping |
| Immunohaematology - Investigation of blood transfusion reactions | Blood products | Antibodies |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP) | Issue and release of blood and blood products for transfusion |
Immunology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies; Anti-double stranded DNA antibodies (dsDNA); Anti-endomysial antibodies (EMA); Anti-extractable nuclear antigen antibodies (ENA); Anti-myeloperoxidase antibodies (MPO); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-proteinase 3 antibodies (PR3); Anti-thyroglobulin antibodies (Tg); Anti-β2-glycoprotein-I antibodies |
| Anti-nuclear antibodies (ANA) | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) | ||
| Rheumatoid factor | ||
| Anti-endomysial antibodies (EMA); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-tissue antigen antibodies | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing [purified native and/or recombinant allergens]) | Serum | Ara h2 - Peanut |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Penicilloyl G; Penicilloyl V |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Cat epithelium; Dog dander |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Egg; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Oyster; Seafood mix; Shrimp |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Omega-5-gliadin; Staple food mix; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Cashew nut; Hazelnut; Nut panel; Peanut; Pistachio; Sesame seed; Soy bean; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Grass mix; Rye grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Aspergillus fumigatus; Candida albicans; Pityrosporum orbiculare (Malassezia furfur); Staphylococcus enterotoxins; Trichophyton rubrum |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Latex; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Tree mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Honey bee venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Weed mix |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Faeces | Calprotectin; Elastase |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
Microbiology & Molecular
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of tumour markers | Faeces | Blood |
| Infertility and pregnancy tests including assisted reproductive technology - Investigation of sperm | Semen | Sperm antibodies |
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) | Semen | Leucocytes (white blood cells, WBC); pH |
| Colour; Liquefaction; Viscosity | ||
| Volume | ||
| Agglutination; Aggregation; Motility | ||
| Differential number; Morphology; Motility; Sperm number | ||
| Differential number; Sperm number | ||
| Morphology; Vitality | ||
| Infertility and pregnancy tests including assisted reproductive technology - Semen analysis for post vasectomy and/or examination of cervical mucus | Semen | Presence of spermatozoa |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); Dry swabs; Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Post-operative wounds; Pus; Rectal swabs; Respiratory specimens; Skin; Sputum; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Pathogenic identification and antibiotic susceptibility; Pathogenic microorganisms |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Nasal swabs; Post-operative wounds; Pus; Rectal swabs; Respiratory specimens; Skin; Sputum; Throat swabs; Tissues; Urethra; Urine; Vaginal swabs; Wound swabs | Pathogenic identification and antibiotic susceptibility; Pathogenic microorganisms | |
| Blood | Pathogenic microorganisms | |
| Faeces | Clostridioides difficile | |
| Clostridioides difficile toxin | ||
| Pathogenic identification and antibiotic susceptibility; Pathogenic microorganisms | ||
| Helicobacter pylori antigen | ||
| Pathogenic identification and antibiotic susceptibility; Pathogenic microorganisms | ||
| Urine | Bacteria; Bilirubin; Blood; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Ketones; Leucocyte esterase; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Specific gravity; Urobilinogen; pH | |
| Bacteria; Bilirubin; Blood; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Ketones; Leucocyte esterase; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Specific gravity; Urobilinogen; pH | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Axilla swabs; Faeces; Nasal swabs; Rectal swabs | Carbapenem resistant Enterobacteriaceae (CRE); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Carbapenem resistant Enterobacteriaceae (CRE); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) | ||
| Carbapenem resistant Enterobacteriaceae (CRE); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Environmental swabs | Yeast organism identification - Candida auris |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Van A/B |
| Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs | Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Mycoplasma pneumoniae | |
| Dry swabs; Genital swabs; Liquid based cytology specimens; Rectal swabs; Throat swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| General swabs | Treponema pallidum | |
| Genital swabs; Liquid based cytology specimens; Rectal swabs; Throat swabs; Urine | Neisseria gonorrhoeae | |
| Genital swabs; Liquid based cytology specimens; Urine | Mycoplasma genitalium | |
| Genital swabs; Urine | Macrolide resistant Mycoplasma genitalium | |
| Mycoplasma genitalium; Mycoplasma hominis; Ureaplasma parvum; Ureaplasma urealyticum | ||
| Nasopharyngeal aspirate; Nasopharyngeal swabs | Bordetella parapertussis; Bordetella pertussis | |
| Rectal swabs; Throat swabs | Mycoplasma genitalium | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium spp.; Entamoeba histolytica; Giardia lamblia |
| Blastocystis spp.; Cryptosporidium spp.; Dientamoeba fragilis; Entamoeba histolytica; Giardia lamblia | ||
| Genital swabs; Liquid based cytology specimens; Urine | Trichomonas vaginalis | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchoalveolar lavage; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Oropharyngeal swabs | Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Bronchoalveolar lavage; Nasopharyngeal and throat swab; Nasopharyngeal aspirate; Sputum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Dry swabs; General swabs; Mucocutaneous swabs | Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Dry swabs; Nasal swabs; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Mucocutaneous swabs; Skin swabs | Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Nasal swabs; Nasopharyngeal and throat swab; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Adenovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasopharyngeal swabs | Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B; Rhinovirus | |
| Plasma | Human immunodeficiency virus (HIV) viral load | |
| Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral RNA | |
| Microbiology - Molecular biology - Surveillance programme for the detection of microbial nucleic acids (viruses) in accordance with Commonwealth and/or State Health protocols | Saliva; Saliva suck swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | General swabs; Other body fluids; Respiratory specimens; Sputum; Tissues; Urine | Mycobacteria identification |
| Other body fluids; Respiratory specimens; Sputum; Tissues; Urine | Mycobacteria identification | |
| Microbiology - Mycobacteriology - Tests for cell mediated immunity | Blood | Latent tuberculosis |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Nails; Skin; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Bronchial lavage; Bronchial washings; Cerebrospinal fluid (CSF); Fluids; General swabs; Nails; Skin scrapings; Sputum; Tissues | Fungi identification; Fungi susceptibility; Yeast susceptibility; Yeasts identification |
| Bronchial lavage; Bronchial washings; Cerebrospinal fluid (CSF); General swabs; Nails; Skin scrapings; Sputum; Tissues | Fungi identification; Fungi susceptibility; Yeast susceptibility; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Parasites |
| Cryptosporidia; Giardia spp.; Cysts; Ova; Parasites | ||
| Skin scrapings | Scabies; Louse; Mites; Ticks | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgM antibody |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Serum | Syphilis Treponema pallidum antibody | |
| Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) neutralisation; Hepatitis C virus (HCV); Human immunodeficiency virus (HIV) | ||
| Cytomegalovirus (CMV) | ||
| Cytomegalovirus (CMV) IgG avidity; Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus (HCV); Hepatitis C virus (HCV) RNA - Quantitative; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mycoplasma total antibody; Parvovirus B19 IgG antibody; Parvovirus B19 IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma; Toxoplasma activity index; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | ||
| Rubella IgG antibody | ||
| Hepatitis A virus (HAV); Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis C virus antibody (anti-HCV) | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Norovirus |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | HLA-B27 |
| HLA-DB locus typing |
Toxicology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Urine | Ethanol; Methadone |
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Legal
Medicare expiry date
11 Jan 2028
Last Activity Date
09 Sep 2024
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2023, Appendix A, Additional and optional testing | Urine | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 2-Oxo-3-hydroxy-lysergide (2-Oxo-3-hydroxy-LSD); 6-Acetylmorphine; 7-Hydroxymitragynine; Buprenorphine; Buprenorphine-3-β-D-glucuronide; Cocaethylene; Dihydrocodeine (6α-hydrocodol); Dihydrocodeine-6-β-D-glucuronide; Dihydromorphine; Etizolam; Fentanyl; Hydrocodone; Kava (kavain); Ketamine; Lysergic acid diethylamide (LSD, lysergide); Meperidine (pethidine); Mescaline; Methadone; Methaqualone; Midazolam; Mitragynine; N-Desmethyl cis tramadol; Naloxone; Norbuprenorphine; Norbuprenorphine-3-β-D-glucuronide; Norfentanyl; Norketamine; Norpethidine; Oxycodone; Phenazepam; Phencyclidine; Propoxyphene; Psilocin; Tapentadol; Tramadol; Triazolam; Zaleplon; Zolpidem; Δ8-Caroboxy-tetrahydrocannabinol; α-Hydroxyetizolam; α-Hydroxymidazolam; α-Hydroxytriazolam |
| Medico legal drug testing AS/NZS 4308:2023, Section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
| Medico legal drug testing AS/NZS 4308:2023, Section 3 Onsite screening test procedure - Testing performed at client sites | Urine | Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates |
| Medico legal drug testing AS/NZS 4308:2023, Section 4 General laboratory requirements | Urine | General laboratory requirements as described in AS/NZS 4308 |
| Medico legal drug testing AS/NZS 4308:2023, Section 5 Laboratory screening procedures | Urine | Amphetamine type substances; Benzodiazepines; Cocaine metabolites; Creatinine; Opiates; Oxidants; pH |
| Medico legal drug testing AS/NZS 4308:2023, Section 6 Laboratory confirmatory procedures | Urine | 11-nor-9-carboxy-Δ9-Tetrahydrocannabinol; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Codeine; Codeine-6-glucuronide (codeine-6-β-D-glucuronide); Diazepam; Dihydrocodeine (6α-hydrocodol); Ephedrine; Methylamphetamine; Methylenedioxyamphetamine; Morphine; Morphine-3-glucuronide (morphine-3-β-D-glucuronide); Morphine-6-glucuronide (morphine-6-β-D-glucuronide); Nordiazepam; Oxazepam; Oxycodone; Phentermine; Pseudoephedrine (PSE); Temazepam; α-Hydroxyalprazolam |
| Medico legal drug testing AS/NZS 4760, appendix B Additional testing | Oral fluid | 2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP); 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; Alprazolam; Clonazepam; Diazepam; Etizolam; Methadone; Midazolam; Nordiazepam; Oxazepam; Phenazepam; Temazepam; Triazolam; α-Hydroxyalprazolam; α-Hydroxymidazolam; α-Hydroxytriazolam |
| Medico legal drug testing AS/NZS 4760, section 3 General laboratory requirements | Oral fluid | General laboratory requirements as described in AS/NZS 4760 |
| Medico legal drug testing AS/NZS 4760, section 4 Laboratory screen testing | Oral fluid | 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Cocaine; Codeine; Methylamphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Oxycodone; Temazepam; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
| Medico legal drug testing AS/NZS 4760, section 5 Laboratory confirmatory procedures | Oral fluid | 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Amphetamines; Benzoylecgonine (ecgonine benzoate); Cocaine; Methylamphetamine; Morphine; Oxycodone; Δ-9-Tetrahydrocannabinol (THC-Δ9) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2133
Site No.
2126
Print date
22 Nov 2024
END OF SCOPE